Chipscreen NewWay Biosciences
Latest round
- Series A
Last raised
- Jul 2025
Total raised
- $39M
Investors
- 3
About Chipscreen NewWay Biosciences
Founded in 2021 and based in Chengdu, China, Chipscreen NewWay Biosciences is a biotechnology company primarily engaged in developing large molecules and other novel therapeutic technologies. The company is an affiliated company of ChipScreen, a biotech company based in Shenzhen, China. Chipscreen NewWay Biosciences utilizes novel therapeutic approaches and technologies, including large molecules such as antibodies and nucleic acid drugs, to develop innovative drugs with novel mechanisms of action that meet clinical needs in multiple therapeutic areas, including oncology, providing patients with new treatment options and novel therapeutic approaches The company generates revenue from developing drugs from large molecules technologies.
Who invested in Chipscreen NewWay Biosciences
3 investors across 2 rounds
See all investors in Chipscreen NewWay Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chipscreen NewWay Biosciences
Who invested in Chipscreen NewWay Biosciences?
Chipscreen NewWay Biosciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chipscreen NewWay Biosciences raised?
Chipscreen NewWay Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Chipscreen NewWay Biosciences last raise money?
Chipscreen NewWay Biosciences's most recent round on record is a Series A, in Jul 2025.
What does Chipscreen NewWay Biosciences do?
Founded in 2021 and based in Chengdu, China, Chipscreen NewWay Biosciences is a biotechnology company primarily engaged in developing large molecules and other novel therapeutic technologies.
Where is Chipscreen NewWay Biosciences headquartered?
Chipscreen NewWay Biosciences is headquartered in Chengdu, China.
Which VCs invest in companies like Chipscreen NewWay Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Chipscreen NewWay Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Chipscreen NewWay Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.